Kiadis Pharma
Kiadis Pharma is a biopharmaceutical company that develops and commercializes T-cell based immunotherapies for the treatment of blood cancer.
Business Model:
Revenue: $25.9M
Employees: 51-200
Industries / Tags:
Detailed Kiadis Pharma Information
Kiadis Pharma was acquired by
Sanofi.
The acquisition happend on 2020-11-02.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Paasheuvelweg 25A
City: Amsterdam
State: zuid-holland
Zip: 1105
Country: NL
Financial Info
Stage:
post ipo equity
Raised Last:
$9M
Raised Total:$89M
Social
Metrics
3,284,889Website Global Rank
4,975Website Monthly Traffic
Twitter Followers
Description
Kiadis Pharma is a biopharmaceutical company that develops and commercializes T-cell based immunotherapies for the treatment of blood cancer.
Contact Phone:
Contact Email:
Kiadis Pharma went public on 7/10/2015 on the NYSE Euronext
Listed Exchange:
NYSE Euronext
IPO Date:
7/10/2015
Ticker Symbol:
KDS
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 4/2019 | CytoSen Therapeutics | |
| 12/2006 | Celmed Biosciences |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
